Société Takeda Pharmaceutical Company Limited BOERSE MUENCHEN

Société Takeda Pharmaceutical Company Limited BOERSE MUENCHEN

TKDA

US8740602052

Produits pharmaceutiques

Consensus des Analystes

Actions

TKDA

US8740602052

Produits pharmaceutiques

Consensus des Analystes

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par activité

Ventes par région

Notations pour Takeda Pharmaceutical Company Limited

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Métier

Ventes par activité

Ventes par région

Dirigeants

Administrateurs

Classe d'actions

Actionnaires

Participations

Coordonnées société

Sociétés du groupe

Secteur

Ventes par activité

Ventes par région

Notations pour Takeda Pharmaceutical Company Limited

Révisions de BNA

Bénéfices trimestriels - Taux de surprise

Secteur Pharmacies - Autres

Temps réel BOERSE MUENCHEN Autres places de cotation 13:43:41 27/06/2024			Varia. 5j.	Varia. 1 janv.
12,1 ^EUR	0,00%		+1,68%	-6,20%

25/06	Les CDC américains alertent les prestataires de soins de santé sur l'augmentation du nombre de cas de dengue	RE
25/06	Un médicament anticancéreux de Takeda reçoit l'approbation de la Commission européenne	MT

Takeda Pharmaceutical Company Limited est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques destinés essentiellement au traitement des maladies métaboliques et cardiovasculaires, des cancers et des troubles du système nerveux central. L'activité s'organise autour de 2 pôles :

- vente de médicaments et de produits de soins grand public ;

- prestations de services.

La répartition géographique du CA est la suivante : Japon (17,5%), Asie (5%), Etats-Unis (49%), Europe et Canada (20,8%), Amérique latine (3,8%), Russie et CEI (1,8%) et autres (2,1%).

JPY en Millions	2023	Poids	2024	Poids	Delta
Gastroenterology 28,5 %	1 094 541	27,2 %	1 216 207	28,5 %	+11,12%
Plasma-derivatives Therapies Immunology 19,2 %	678 443	16,8 %	818 570	19,2 %	+20,65%
Neuroscience 14,7 %	637 711	15,8 %	627 014	14,7 %	-1,68%
Rare Genetics and Other 10,9 %	418 724	10,4 %	465 403	10,9 %	+11,15%
Oncology 10,8 %	438 742	10,9 %	462 362	10,8 %	+5,38%
Other 8,7 %	454 598	11,3 %	368 908	8,7 %	-18,85%
Rare Hematology 7,2 %	304 718	7,6 %	305 297	7,2 %	+0,19%

JPY en Millions	2023	Poids	2024	Poids	Delta
United States 51,5 %	2 103 772	52,2 %	2 195 711	51,5 %	+4,37%
Europe and Canada 22,7 %	842 668	20,9 %	966 835	22,7 %	+14,73%
Japan 10,6 %	512 043	12,7 %	451 391	10,6 %	-11,85%
Asia 6,1 %	225 007	5,6 %	261 218	6,1 %	+16,09%
Latin America 4,6 %	160 375	4,0 %	198 100	4,6 %	+23,52%
Other 2,8 %	95 182	2,4 %	117 911	2,8 %	+23,88%
Russia / Commonwealth of Independent States 1,7 %	88 431	2,2 %	72 594	1,7 %	-17,91%

Dirigeants	Titre	Age	Depuis
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Mwana Lugogo CMP	Compliance Officer	54	01/01/12
Michael Mendelsohn CTO	Chief Tech/Sci/R&D Officer	69	01/04/15
Andrew Plump CTO	Chief Tech/Sci/R&D Officer	58	01/02/15
Gabriele Ricci CTO	Chief Tech/Sci/R&D Officer	45	01/02/22
Norimasa Takeda CMP	Compliance Officer	-	-
Haruhiko Hirate IRO	Public Communications Contact	-	-
Takashi Okubo IRO	Public Communications Contact	-	-
Christopher O'Reilly IRC	Investor Relations Contact	-	01/06/11
Marcello Agosti PRN	Corporate Officer/Principal	53	01/01/19

Administrateurs	Titre	Age	Depuis
Yoshiaki Fujimori BRD	Director/Board Member	71	01/06/16
Ian Clark BRD	Director/Board Member	62	01/01/19
Steven Gillis BRD	Director/Board Member	71	01/01/19
John Maraganore BRD	Director/Board Member	60	01/06/22
Emiko Higashi BRD	Director/Board Member	64	01/06/16
Michel Orsinger BRD	Director/Board Member	66	01/06/16
Christophe Weber CEO	Chief Executive Officer	57	01/04/14
Andrew Plump CTO	Chief Tech/Sci/R&D Officer	58	01/02/15
Kimberly Reed BRD	Director/Board Member	53	01/06/22
Miki Tsusaka BRD	Director/Board Member	61	01/04/23

	Vote	Nombre	Flottant	Autocontrôle	Flottant Total
Action A	0	1 582 418 725	1 568 501 201 ( 99,12 %)	13 405 261 ( 0,8471 %)	99,12 %

Nom	Actions	%	Valorisation
BlackRock Fund Advisors 3,496 %	55 319 129	3,496 %	1 469 M €
BlackRock Japan Co. Ltd. 2,276 %	36 020 800	2,276 %	957 M €
Nikko Asset Management Co., Ltd. 2,194 %	34 711 100	2,194 %	922 M €
Nippon Life Insurance Co. 1,564 %	24 752 000	1,564 %	657 M €
Takeda Science Foundation 1,132 %	17 912 000	1,132 %	476 M €
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0,4747 %	7 511 300	0,4747 %	199 M €
BlackRock Investment Management (UK) Ltd. 0,3774 %	5 972 275	0,3774 %	159 M €
BlackRock (Netherlands) BV 0,2850 %	4 509 380	0,2850 %	120 M €
Takeda Pharmaceutical Employee Incentive Plan 0,2294 %	3 630 339	0,2294 %	96 M €
IYOGIN HOLDINGS,INC. 0,1818 %	2 876 136	0,1818 %	76 M €

Nom	Actions	%	Valorisation
Nikko Asset Management Co., Ltd. 2,762 %	87 400 834	2,762 %	1 167 M €
Capital Research & Management Co. (Global Investors) 0,4146 %	13 121 930	0,4146 %	175 M €
Mondrian Investment Partners Ltd. 0,3817 %	12 079 962	0,3817 %	161 M €
Eaton Vance Management 0,1578 %	4 995 623	0,1578 %	67 M €
The Ayco Co. LP 0,1330 %	4 209 431	0,1330 %	56 M €
Renaissance Technologies LLC 0,0985 %	3 118 200	0,0985 %	42 M €
Brandes Investment Partners LP 0,0917 %	2 902 507	0,0917 %	39 M €
Fidelity Management & Research Co. LLC 0,0813 %	2 574 240	0,0813 %	34 M €
Wells Fargo Bank NA 0,0813 %	2 571 467	0,0813 %	34 M €
Millennium Management LLC 0,0734 %	2 322 444	0,0734 %	31 M €

Nom	Actions	%	Valorisation
BB Gestão de Recursos DTVM SA 0,000068 %	1 076	0,000068 %	14 302 €

Nom	Actions	%	Valorisation
TAKEDA PHARMACEUTICAL COMPANY LIMITED 0,47%	7 514 200	0,47%	199 540 257 $
HILLEVAX, INC. 13,52%	6 724 000	13,52%	81 629 360 $
DENALI THERAPEUTICS INC. 2,96%	4 214 559	2,96%	78 222 215 $
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD. 7,21%	2 204 000	7,21%	33 085 588 $
OVID THERAPEUTICS INC. 12,38%	8 781 996	12,38%	26 872 908 $
PHATHOM PHARMACEUTICALS, INC. 4,77%	2 790 480	4,77%	26 286 322 $
WAVE LIFE SCIENCES LTD. 0,90%	1 096 892	0,90%	6 778 793 $
NOILE-IMMUNE BIOTECH INC. 18,76%	8 119 800	18,76%	6 768 828 $

Takeda Pharmaceutical Co., Ltd.

4-1-1 Dosho-machi Chuo-Ku

540-8645, Osaka

+81 3 3278-2111

http://www.takeda.co.jp

Adresse Takeda Pharmaceutical Company Limited(TKDA)

Nom	Catégorie et Secteur
Shire Biotech India Pvt Ltd.
Takeda Austria GmbH Takeda Austria GmbH Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Austria GmbH engages in research and development of pharmaceutical products. The company is based in Linz, Austria. Kirsten Detrick has been the CEO of the Austrian company since 2016.	Miscellaneous Commercial Services
Takeda Belgium NV Takeda Belgium NV Medical DistributorsDistribution Services Founded in 1835, Takeda Belgium NV is a subsidiary of Takeda Pharmaceutical Co., Ltd. The company is based in Zaventem, Belgium and focuses on providing better healthcare solutions for their patients. Takeda Belgium's mission is centered around the question of how they can do more for their patients.	Medical Distributors
Takeda Pharmaceuticals U.S.A., Inc. Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL.	Pharmaceuticals: Major
Takeda GmbH Takeda GmbH Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Konstanz, Germany. The CEOs are Wolfgang Eck, Uwe Hoffmeister, Roland Kurney. The company was founded in 1873.	Pharmaceuticals: Major
Shire Ireland Finance Trading Ltd.
Shire Biotech UK Holdings Ltd. Shire Biotech UK Holdings Ltd. Financial ConglomeratesFinance Part of Takeda Pharmaceutical Co., Ltd., Shire Biotech UK Holdings Ltd. is an investment holding company. Shire Biotech UK Holdings Ltd. is based in London, UK. Founded in 2017, Shire Biotech UK Holdings functions as an investment holding company.	Financial Conglomerates
Takeda Manufacturing Austria AG Takeda Manufacturing Austria AG Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda Manufacturing Austria AG manufactures and supplies vital medicines and medical devices. The company is based in Vienna, Austria.	Pharmaceuticals: Major
Takeda A/S Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.	Financial Conglomerates
Takeda Pharmaceuticals International AG Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.	Pharmaceuticals: Major

Note Trading

Note Investissement

ESG Refinitiv

Plus de notations

Vente

Achat

Recommandation moyenne

ACCUMULER

Nombre d'Analystes

Dernier Cours de Cloture

4 168 JPY

Objectif de cours Moyen

4 744 JPY

Ecart / Objectif Moyen

+13,83%

Consensus

Révisions des Estimations

Agenda de la société

	Varia. 1 janv.	Capi.
ELI LILLY AND COMPANY	+54,61%	811 Md
NOVO NORDISK A/S	+43,48%	640 Md
JOHNSON & JOHNSON	-6,33%	353 Md
MERCK & CO., INC.	+20,62%	333 Md
ABBVIE INC.	+10,44%	302 Md
ASTRAZENECA PLC	+17,53%	246 Md
ROCHE HOLDING AG	+2,37%	225 Md
NOVARTIS AG	+12,57%	218 Md
AMGEN INC.	+8,61%	168 Md

Pharmacies - Autres

Recherche pharmaceutique et médicale

Produits pharmaceutiques

Produits pharmaceutiques

Pharmacies - Autres